| reference | Towler, M.C., and Hardie, D.G. , AMP-activated protein kinase in metabolic control and insulin signaling. Circ. Res. 100, 328-341, (2007) Abstract |
| | Isakovic, A., et al., Dual antiglioma action of metformin: cell cycle arrest and mitochondria-dependent apoptosis. Cell. Mol. Life Sci. 64, 1290-1302, (2007) Abstract |
| | Zakikhani, M., et al., Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells. Cancer Res. 66, 10269-10273, (2006) Abstract |
| | Shaw, R.J., et al., The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310, 1642-1646, (2005) Abstract |
| | Leverve, X.M., et al., Mitochondrial metabolism and type-2 diabetes: a specific target for metformin. Diabetes Metab. 29, 6S88-6S94, (2003) Abstract |
| | Towler, M.C., and Hardie, D.G., AMP-activated protein kinase in metabolic control and insulin signaling. Circ. Res. 100, 328-341, (2007) |
| | Zakikhani, M., et al., , Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells. Cancer Res. 66, 10269-10273, (2006) |
| | Isakovic, A., et al., , Dual antiglioma action of metformin: cell cycle arrest and mitochondria-dependent apoptosis. Cell. Mol. Life Sci. 64, 1290-1302, (2007) |
| | Shaw, R.J., et al., , The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310, 1642-1646, (2005) |
| | Leverve, X.M., et al., , Mitochondrial metabolism and type-2 diabetes: a specific target for metformin. Diabetes Metab. 29, 6S88-6S94, (2003) |
| Merck | Merck 13,5963 |
| | Aldrich MSDS 1, 758:C / Corp MSDS 1 (1), 1358:A / FT-IR 2 (1), 1393:A / IR-Spectra (2), 431:D / IR-Spectra (3), 487:G / RegBook 1 (1), 965:K / Structure Index 1, 150:D:4 |